BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 10521419)

  • 1. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
    Yuan H; Mao J; Li L; Wu D
    J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1.
    Li L; Yuan H; Weaver CD; Mao J; Farr GH; Sussman DJ; Jonkers J; Kimelman D; Wu D
    EMBO J; 1999 Aug; 18(15):4233-40. PubMed ID: 10428961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C; Weiss JB; Williams LT
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling through beta-catenin and Lef/Tcf.
    Novak A; Dedhar S
    Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.
    Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Cherqui G; Perret C; Capeau J
    Oncogene; 2001 Jan; 20(2):252-9. PubMed ID: 11313952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt participation in the Wnt signaling pathway through Dishevelled.
    Fukumoto S; Hsieh CM; Maemura K; Layne MD; Yet SF; Lee KH; Matsui T; Rosenzweig A; Taylor WG; Rubin JS; Perrella MA; Lee ME
    J Biol Chem; 2001 May; 276(20):17479-83. PubMed ID: 11278246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
    Staal FJ; Burgering BM; van de Wetering M; Clevers HC
    Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin.
    Hedgepeth CM; Deardorff MA; Rankin K; Klein PS
    Mol Cell Biol; 1999 Oct; 19(10):7147-57. PubMed ID: 10490650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional domains of axin. Importance of the C terminus as an oligomerization domain.
    Sakanaka C; Williams LT
    J Biol Chem; 1999 May; 274(20):14090-3. PubMed ID: 10318824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
    Jho Eh; Lomvardas S; Costantini F
    Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification.
    Farr GH; Ferkey DM; Yost C; Pierce SB; Weaver C; Kimelman D
    J Cell Biol; 2000 Feb; 148(4):691-702. PubMed ID: 10684251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. I-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways.
    Kusano S; Raab-Traub N
    Mol Cell Biol; 2002 Sep; 22(18):6393-405. PubMed ID: 12192039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
    Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER
    J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New steps in the Wnt/beta-catenin signal transduction pathway.
    Sakanaka C; Sun TQ; Williams LT
    Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos.
    Yamamoto H; Kishida S; Uochi T; Ikeda S; Koyama S; Asashima M; Kikuchi A
    Mol Cell Biol; 1998 May; 18(5):2867-75. PubMed ID: 9566905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Wnt signaling pathway by a novel axin-binding protein.
    Kadoya T; Kishida S; Fukui A; Hinoi T; Michiue T; Asashima M; Kikuchi A
    J Biol Chem; 2000 Nov; 275(47):37030-7. PubMed ID: 10944533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Wnt signaling by Axin and Axil.
    Kikuchi A
    Cytokine Growth Factor Rev; 1999; 10(3-4):255-65. PubMed ID: 10647780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the Axin and Frat binding region of glycogen synthase kinase-3.
    Fraser E; Young N; Dajani R; Franca-Koh J; Ryves J; Williams RS; Yeo M; Webster MT; Richardson C; Smalley MJ; Pearl LH; Harwood A; Dale TC
    J Biol Chem; 2002 Jan; 277(3):2176-85. PubMed ID: 11707456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
    Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
    EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.